Yeh Chen Lee

Has grant

Conjoint Senior Lecturer

University of New South Wales

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Tislelizumab plus chemotherapy after post-operative pelvic chemoradiation in high risk endometrial cancer: the ADELE study

Open Date: 2020-01-01

Close Date:

Grant: Close

The Interprofessional Malignant Bowel Management Program

Open Date: 2018-05-01

Close Date: 2018-05-01

Grant: Close

Malignant Bowel Obstruction

Open Date: 2017-08-01

Close Date: 2018-08-01

Grant: Close

A pilot study to define short term responders in patients with ovarian cancer who carry germline BRCA1/2 mutation

Open Date: 2017-04-01

Close Date: 2018-12-01

Articles (17)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

CANADA

View details

Carolina X Sandler

Lecturer

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yeh Chen Lee

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (17)

Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer

Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: Design and implementation of a randomised controlled trial

Association of chemotherapy dose intensity and age with outcomes in patients with Ewing's family sarcoma

A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers

Adjuvant chemotherapy for locally advanced cervical cancer – Authors’ reply

Managing Adverse Effects Associated With Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer: A Synthesis of Clinical Trial and Real-World Data

Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial

Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice

Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA)

Management of Malignant Bowel Obstruction

Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer

Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients

GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee

Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study

Interobserver and intraobserver variability of RECIST assessment in ovarian cancer

TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members

Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020)

Collaborators (11)

Sandra Hayes

Mary-Anne Young

Monika Janda

Rosalind Spence

Amit M Oza

Carolina X Sandler

Gisela Mir Arnau

Annamaria Ferrero

Peter Grimison

Kate Pumpa

Louisa Gordon

Make your next move.